CV: Martin I Resnick MD

Martin I Resnick, MD
Formerly
Department of Urology
University Hospitals
School of Medicine
Case Western Reserve University

NetWellness Articles associated with this Author:

	Article Name	Forum
	Kidney Stones	Kidney Diseases
	Introduction	Prostate Cancer
	Screening for Prostate Cancer	Prostate Cancer
	Risk Factors for Prostate Cancer	Prostate Cancer
	PSA Testing	Prostate Cancer
	Biopsy of the Prostate	Prostate Cancer
	Medications for Treating Prostate Cancer	Prostate Cancer
	Treatment Options for Prostate Cancer	Prostate Cancer
	Prostate Cancer: A Major Health Concern for African American Men	African American Health
	Incontinence Overview	Incontinence
	Incontinence and the Body	Incontinence
	Incontinence Risk Factors	Incontinence
	Incontinence Treatment Options	Incontinence
	Incontinence Prevention	Incontinence
	Urinary Tract Cancers Overview	Urinary Tract Cancers
	Kidney Cancer	Urinary Tract Cancers
	Bladder Cancer	Urinary Tract Cancers
	Testicular Cancer	Urinary Tract Cancers
	Diagnosis and Staging of Prostate Cancer	Prostate Cancer
	Surgical Treatments for Prostate Cancer	Prostate Cancer
	Radiation Treatment of Prostate Cancer	Prostate Cancer
	Symptoms of Prostate Cancer	Prostate Cancer
	Urinary Disorders Overview	Urinary Disorders
	Urinary Tract Infections	Urinary Disorders
	Prostate Enlargement (BPH)	Urinary Disorders

Programs:

The Urology Department at University Hospitals of Cleveland: All aspects of diagnostic and surgical urology are available for both pediatric and adult patients. Special programs include pediatric urology, urologic oncology, neurogenic bladder, spinal cord injury, renal lithiasis and lithotripsy, infertility, impotence, female urology and incontinence. Special diagnostic outpatient services include cystoscopy, cystometrics, prostate ultrasonography and plethysmography.

Education:

Alfred University, Alfred, New York - B.A., 1964
Bowman Gray School of Medicine, Winston-Salem, North Carolina, M.D., 1969

Post Graduate Training:

George Washington University, Washington, D.C., 1964-1965
Northwestern University, Chicago, Illinois, M.S., 1973
University Hospitals of Cleveland, Cleveland, Ohio, Internship, July 1, 1969 - June 30, 1970
Junior Assistant Resident, University Hospitals of Cleveland, Surgery, July 1, 1970 - June 30, 1971
Resident in Urology, Northwestern University Medical Center, July 1971 - June 1975

Licensure or Certification:

National Board of Medical Examiners (#107326) - 1970
American Board of Urology - 1977
Ohio (#32355) - 1970
Illinois (#36-46507) - 1972
North Carolina (#20331) - 1975

Associations:

American Urological Association, Secretary, 1997-present
National Kidney Foundation, Public Policy Committee, 1992-1993
National Institutes of Health, Urology Program Advisory Group - NIDDK, 1990-present
Society of University Urologists, Executive Committee 1987-present
American Medical Association, Continuing Medical Education Advisory Committee, 1994
Pan-Pacific Surgical Association, Vice President, 1990-1998
American Cancer Society, Ohio Division, Trustee-at-Large 1993-1997
Department of Veterans Affairs/ National Cancer Institute, Member, Data Monitoring Board VA/NCI Cooperative Study 407 Prostate Cancer Intervention Versus Observation Trial (PIVOT), 1994-present
American College of Surgeons, Governor, 1995-2000
American College of Radiology, Appropriateness Criteria Panel Member - Interventional Radiology 1997-1998
American Board of Urology, Trustee, 1997-2003
American Foundation of Urologic Disease, Board of Directors, 1997-present
Association of American Medical Colleges, Faculty Practice Governance Representative, 1996-present
American Urological Association, President, 2003-2004

Partial List of Publications:

Mohan RR, Challa A, Gupta S, Bostwick DG, Ahmad N, Agarwal R, Marengo SR, Amini SB, Paras F, MacLennan GT, Resnick MI and Mukhtar H: Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. Clinical Cancer Research 5:143-147, 1999.
Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH, Castellanos R, Coffield S, Saltzman B, Resnick M, Cook TJ, Waldstreicher J: Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Urology 53: 473-480, 1999.
Kahan SE, Seftel AD, Resnick MI: Postmortem sperm procurement: A legal perspective. J. Urol 61:1840-1843, 1999.
Catalona WJ, Oesterling JE, Resnick MI: Current recommendations on PSA testing. Patient Care 32:58-83, 1998.
Haas CA, Resnick MI, Abdul-Karim FW: Cavernous hemangioma presenting as a renal hilar mass. J.Urol. 160:2139-2140, 1998.
Haas CA, Bodner DR, Hampel N, Resnick MI: Systemic candidiasis presenting with prostatic abscess. Brit. J. Urol. 82:450-451, 1998.
McGrother C, Resnick MI, Yalla SV, Kirschner-Hermanns R, Broseta E, Muller C, Welz-Barth A, Fischer GC, Mattelaer J, McGuire EJ: Epidemiology and etiology of urinary incontinence in the elderly. World J. Urol (Suppl) l6:S3-S9, 1998.
Brown SL, Persky L, Resnick MI: Bladder injury - Intraperitoneal and extraperitoneal. Atlas Urol Clinics of NA 6:59-70, 1998.
Wegryn JD, Resnick MI: Angiomyolipoma: Diagnosis and conservative management. Contemporary Urology 10:55-61, 1998.
Corriere J, Bobin ER, Bruckman T, Hudson T, Kaufman A, Lee C, Pagano F, Puras Baez AP, Putzeys T, Resnick MI, Rodrigues Netto N, Schroeder F, Vela Neverette R: Benign prostatic hyperplasia: Education and ethics. In: 4 International Consultation on Benign Prostatic Hyperplasia (BPH), editors L Denis, K Griffith, S Khoury, ATK Cockett, J McConnell, C Chatelain, G Murphy, O Yoshida, Health Publishing Limited, United Kingdom, 1998.
Rutchik SD, Resnick MI: The epidemiology of incontinence in the elderly. Brit. J. Urol. 82:(Supplement 1)1-4, 1998.
Rutchik SD, Resnick MI: Ureteropelvic junction obstruction and renal calculi: Pathophysiology and implications for management. Urologic Clinics of NA 25:317-321, 1998.
Marengo SR, Resnick MI, Yang L, Chung JY: Differential expression of urinary inter-a-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men. J. Urol. 159:1444-1450, 1998.
Paik ML, Resnick MI: Open surgical approaches to partial and complete staghorn calculi. Atlas of the Urologic Clinics of NA 6:119-128, 1998.
Paik ML, Wainstein MA, Spirnak JP, Hampel N, Resnick MI: Current indications for open stone surgery in the treatment of renal and ureteral calcul. J. Urol 195:374-379, 1998.
Pak CYC, Resnick MI, Preminger GM: Ethnic and geographic diversity of stone disease. Urology 50:504-507, 1997.
Brown SL, Resnick MI: Prostate ultrasound and biopsy. Journal of Medical Ultrasound Volume 5 (Supplement 3) 43-46, 1997.
Paik ML, Resnick MI: The role of open surgery in the management of urolithiasis. Techniques in Urology 3:96-99, 1997.
Carlin BI, Rutchik SD, Resnick MI: Comparison of ileal conduit to the continent cutaneous diversion and orthotopic neobladder in patients undergoing cystectomy: A critical analysis and review of the literature. Seminars in Urologic Oncology 15:189-192, 1997.
Haas CA, Resnick MI: Office-based ultrasound for urologists. AUA Update 31:242-247, 1997.
Carlin BI, Bodner DR, Spirnak JP, Resnick MI: Rose of finasteride in the treatment of recurrent hematuria secondary to benign prostatic hyperplasia. Prostate 31:180-182, 1997.
Grover PK, Resnick MI: High resolution two-dimensional electrophoretic analysis of urinary proteins of patients with prostatic cancer. Electrophoresis 18:814-818, 1997.
Resnick, MI, Smith JA, Scardino PT, Egger MJ, Hernandez A, Rose SC: Transrectal prostate ultrasonography: Variability of interpretation. J. Urol. 158:856-860, 1997.
Carlin BI, Seftel AD, Resnick MI, Findlay J: Finasteride induced gynecomastia. J. Urol. 158:547, 1997.
Wainstein MA, Resnick: Use of polyglycolic acid mesh to support parenchymal closure following partial nephrectomy. J. Urol. 158:526-527, 1997.
Southerland SE, Reigle MD, Seftel AD, Resnick MI: Protease inhibitors in urolithiasis. J. Urol. 158:31-33, 1997.
Smith JA, Jr, Scardino PT, Resnick MI, Hernandez ED, Rose SE, Egger MJ: Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: Results of a prospective multi-institutional trial. J. Urol. 157:902-906, 1997.
Sandock DS, Seftel AD, Resnick MI: The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma. J. Urol. 157:798-799, 1997.
Rutchik SD, Resnick MI: Cystine calculi: Diagnosis and management. Urol. Clin. NA 24:163-171, 1997.
Tobocman W,Resnick MI, Pretlow TG: Ultrasound reflections fail to reflect the histopathology of the prostate. The Prostate 30:33-40, 1997.
Sandock DS, Seftel AD, Resnick MI: Adrenal metastases from renal cell carcinoma: Role of ipsilateral adrenalectomy and definition of stage. Urology 49:28-31, 1997.
Rosner TT, Heyman EN, Resnick MI: Meeting the unspoken needs of prostate cancer patients. Contemporary Urology 9:89-104, 1997.
Rees MA, Resnick MI, Oesterling JE: Use of prostate specific antigen, Gleason's score and digital rectal examinations in staging patients with newly diagnosed prostate cancer. Urol. Clin. NA 24:379-388, 1997.
Stovsky MD, Resnick MI: The diagnosis, prevention and treatment of margin positive disease after radical prostatectomy for adenocarcinoma of the prostate. AUA Update Series Vol. 26:57-64, 1997.
Matthews LA, Doershuk CF, Stern RC, Resnick MI: Urolithiasis and cystic fibrosis. In: Urolithiasis 1996. CYC Pak, MI Resnick, GM Preminger, editors, Millet The Printer, Inc., Dallas, 1996, p 558.
Schor N, Resnick MI: Overview on medical therapy and diagnosis. In: Urolithiasis 1996. CYC Pak, MI Resnick, GM Preminger, editors, Millet The Pringer, Inc., Dallas, 1996, pp, 417.
Marengo SR, Yae-Jong Chung LY, Resnick MI: Alterations in excreted proteins in normal as compared to individuals with active calcium oxalate stone disease. In: Urolithiasis 1996. CYC Pak, MI Resnick, GM Preminger, editors, Millet The Pringer, Inc., Dallas, 1996, pp 297.
Paik ML, Wainstein MA, Spirnak JP, Hampel N, Resnick MI: Current role of open stun surgery. In: Urolithiasis 1996. CYC Pak, MI Resnick, GM Preminger, editors, Millet The Printer, Inc., Dallas, 1996, pp 106.
Carlin BI, Grasso AW, Pretlow TG, Pretlow TP, Resnick MI: Absence of 5 alpha reductase in the prostate cancer xenograft CWR22 and prostate cancer cell lines LNCaP, DU145, and MLC-SV40:Failure to finasteride to affect the in vitro growth of CWR22 prostate cancer xenograft. Surgical Forum 47:820-822, 1996.
Carlin BI, Resnick MI: Assessment of the patient with benign prostatic hyperplasia. Comprehensive Therapy 22:586-591, 1996.
Resnick MI: Postgraduate education and journal editorship. Bulletin American College of Surgeons 81:25-28, 1996.
Mattahews LA, Doershuk CF, Stern, RC, Resnick MI: Urolithiasis and cystic fibrosis. J. Urol. 155:1563-1564, 1996.
Resnick MI: Radical prostatectomy: The perineal approach. Urology 47:457-459, 1996.
Reigle MD, Sandock DS, Resnick MI: When a foley catheter won't deflate. Contemporary Urology 8:51, 1996.
Resnick MI, Schellhammer PF: Radical perineal or retropubic prostatectomy? Contemporary Urology 8:40, 1996.
Haas, CA, Resnick MI: Laparoscopic pelvic and ara-aorta/ retroperitoneal lymph node dissection. Seminars in Laparoscopic Surgery 3:61-74, 1996.
Matthews LA, Resnick MI: Current management of infection-related renal calculi. Cliniguide to Urological Conditions 1:1, 1996.
Selzman AA, Resnick MI: Use of transrectal ultrasound and biopsy in the detection of prostate cancer. Techniques in Urology 1:209-216, 1995.
Wainstein MA, Graham RC, Resnick MI: Predisposing factors of systemic fungal infections on the genitourinary tract. J. Urol. 154:160-163, 1995.
Sandock DS, Seftel AD, Resnick MI: New protocol for follow-up of renal cell carcinoma based on pathologic state. J. Urol. 154:28-31, 1995.
Carlin BI, Resnick MI: Anatomic approach to radical perineal prostatectomy. Urol. Clin NA 22:461-473, 1995.
Scheckowitz EM, Resnick MI: Imaging of the prostatae: Benign prostatic hyperplasia. Urol. Clin NA 22:332, 1995.
Middleton RG, Thompson IN, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Miller HC, Oesterling JE, Resnick MI, Smalley SR, Wasson JH: Prostate Cancer Clinical Guideline Panel Summary Report on the management of clinically localized prostate cancer. J. Urol . 154:2144-2148, 1995.
Stovsky, M, Resnick MI: Understanding healthcare's effect on GNP. Contemporary Urol. 7:13, November 1995.
Wainstein MA, Resnick MI: Management of nosocomial infection with c-3-difficile. Contemporary Urol. 7:56, 1995.
Stovsky MD, Seftel AD, Resnick MI: Delayed hypersensitivity reaction after infusion of non-ionic intravenous contrast material for excretory urogram: Case report and a review of the literature. J. Urol. 153:1640-1643, 1995.
Seftel AD, Herbener TE, Becker M, Aron D, Resnick MI: Focal inflammation of corpus cavernosum in diabetic man due to acute occlusion of cavernous artery. J. Urol. 153:1622-1624, 1995
Grover, PK, Resnick MI: Evidence for the presence of abnormal proteins in urine of recurrent stone formers. J. Urol. 153:1716-1721, 1995.
Grover PK, Resnick MI: Analysis of prostatic fluid: Evidence for the presence of a prospective marker for prostate cancer. The Prostate 26:12-18, 1995.
Calcino R, Chodak GW, Garnick MB, Kuban DH, Resnick MI: Getting the most out of PSA testing. Patient Care 29:104-109, 1995.
Calciano R, Chodak GW, Garnick MB, Kuban DA, Resnick MI: Prostate cancer conundrum. Patient Care 29:84-103, 1995.
Carlin BI, Resnick MI: Indications and techniques for urologic evaluation of the trauma patient with suspected urologic injury. Seminars in Urology 13:9-24, 1995.
Bernsley C, Resnick MI: A salvage-oriented approach to iatrogenic splenic injury. Contemporary Urology 7:61-73, 1995.

Hospital Appointments:

Vice Chairman, Department of Urology, University Hospitals of Cleveland, 1981-present
University Faculty Practice Association, President, 1996-present
Clinical Leadership Committee, 1994-present
Chairman, Search Committee for Director, Department of Pathology, 1997-1998

Grants:

American Geriatric Society, Geriatric Education Center, 1998-2000
NIH 1 RO1 DK55528 Inter-Alpha Trypsin Inhibitor in Calcium Oxalate Urolithiasis, Co-Investigator, September 1998-June 2003
Clinical investigation of high intensity flocused ultrasound (HIFU) for the treatment of benign prostatic hyperplasia (BPH) focus surgery, Indianapolis, IN - February 1999 - present (Principal Investigator)
A Phase III Multicenter Open Label Randomized Study of Abarelix Depto vs. Lupron Depot Plus Casodex In Patients with Prostate Cancer Who are Candidates for Initial Hormone Therapy, Praecis, Cambridge, MA - September 1998 - Present (Principal Investigator)
Efficacy and Safety of Alfuzosin Once-Daily Tablets at 2 Dosage Levels (10 mg and 15 mg) Versus Placebo in Patients with Symptomatic Benign Prostatic Hyperplasia: A Placebo Controlled Double-Blind Study Conducted in 3 parallel Groups for Three Months Followed by a 9 Month Open-Label Extension Study of Alfuzosin OD (15 mg)Synthelabo, Secaucus, NJ, February 1998 - Present (Principal Investigator)
A Randomized, Double-Blind Study (with Open-Label Treatment Extension) to Evaluate the Efficacy and Safety of Viagra (Sildenafil) in Men with Symptoms of Depression and Erectile Dysfunction, Pfizer Pharmaceuticals, Inc., New York, NY - January 1998 - November 1998 (Co-Investigator)
Dose Escalation Study with Tolterodine in Patients with Overactive Bladder. A Single-Blind Study in Patients with Symptoms of Overactive Bladder, Including Urinary Urgency and Frequency with or with Urge Incontinence Parmacia-Upjohn, Kalamazoo, MI - January 1998 - Present, (Co-Investigator)
A Phase III Efficacy and Safety Study of Four Fixed Doses of Apomorphine SL Tablets Versus Placebo in the Treatment of Male Erectile Dysfunction Tap Pharmaceuticals, Inc., Deerfield, IL, December 1997 - August 1998, (Co-Investigator)
A Multi-Center, Open-Label Dose Escalation Study of the Safety and Therapeutic Effects of PPI-149 Depot, Administration as an Intramuscular or Subcutaneous Injection in Prostate Cancer - Patients who are Candidates for Initial Hormonal Therapy, Praecis Pharmaceuticals, Inc., Cambridge, MA, December 1997 - Present, (Principal Investigator)
Double-Blind, Randomized, Placebo-Controlled Two Center Three-Way Crossover Safety and Efficacy Study of the Paroxetine Hydrochloride Capsules for the Treatment of Premature Ejaculation Pentech Pharmaceuticals, Wheeling, IL, June 1997 - January 1999, (Co-Investigator)
A Phase II Open Randomized Multicenter Trial to Determine the Efficacy and Safety of the Combination of Liarozole with Prednisone in Patients with Relapsed Hormone-Resistant Prostate Cancer, Janssen Pharmaceuticals, Janssen at Washington Crossing, Titusville, New Jersey, July 1997 - November 1997, (Principal Investigator)
A Treatment IND Protocol for the Compassionate Use of Elmiron for Patients with Recurring Symptoms of Interstitial Cystitis, Baker Norton Pharmaceuticals, Inc., Miami, Florida, March 1994-present, (Co-Investigator)
A Four Year Open Label Multicenter Study of Oral Episteride 80 mg Once Daily in the Treatment of Benign Prostatic Hyperplasia, Smith Kline Beecham Pharmaceuticals, King of Prussia, Pennsylvania, June 1996 - August 1996, (Principal Investigator)
A Multicenter Phase 111B Open Label Study of Intracavernous Injections of Alprostadil Alphadex in the Treatment of Erectile Dysfunction in Patients with Insulin Dependent Diabetes Mellitus, Schwarz Pharmaceuticals/Bio Clinical Austin, Texas, March 1996 - January 1998, (Co-Investigator)
A Two Year, Open Label, Multi Center Study of Oral Episteride 80 mg Once Daily in the Treatment of Benign Prostatic Hyperplasia, Smith Kline Beecham Pharmaceuticals, King of Prussia, Pennsylvania, 1993-1995, (Principal Investigator)
An Open-Label Study of Intra- cavernous Injections of Alprostadil Alphadex for use in the Diagnosis of Erectile Dysfunction by Doppler Ultrasound, Schwarz Pharmaceuticals Milwaukee, Wisconsin, November 1994 - July 1995, (Co-Investigator)

Awards:

John T. Grayhack Award, Chicago Urological Society, January 7, 1998
William P. Burpeau Award of the Academy of Medicine of New Jersey Section of Urology, May 3, 1995
Distinguished Contribution Award, American Urological Association, 1995
Russell and Mary Hugh Scott Education Award, American Foundation for Urologic Disease, 1993
Award for Excellence, Teton Urological Society, 1991
Neal Award, For Contemporary Urology Editorials, 1991
Australasia College of Surgeons, Foundation Fellow, 1990
Honorary Member, Southeastern Section, American Urological Association, 1987
Gold Cystoscope Award, American Urological Association, 1985
Third Prize Exhibit, Real Time Sonography in Congenital Cystic Disease, American Urological Association, Boston, Massachusetts, May 10-14, 1981
Outstanding Scientific Exhibit Award, South Central Section AUA Association, Kansas City, Missouri, October 12-15, 1980
Physician's Recognition Award, 1980